{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:23:01Z","timestamp":1784067781873,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-108-185"],"award-info":[{"award-number":["DMR-108-185"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2314-B-039-012"],"award-info":[{"award-number":["103-2314-B-039-012"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2314-B-039-007"],"award-info":[{"award-number":["MOST 107-2314-B-039-007"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jfma.2025.12.042","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T12:22:59Z","timestamp":1767356579000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical implications of fibrosis marker dynamics after hepatitis C cure: Insights from paired biopsies"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-1561","authenticated-orcid":false,"given":"Hung-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ping","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0738-417X","authenticated-orcid":false,"given":"Wei-Fan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6086","authenticated-orcid":false,"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jfma.2025.12.042_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2020.10.016","article-title":"HCC surveillance after SVR in patients with F3\/F4 fibrosis","volume":"74","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2025.12.042_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/hep.22745","article-title":"Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient","volume":"49","author":"Calvaruso","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","article-title":"Impact of non-invasive biomarkers on hepatology practice: past, present and future","volume":"76","author":"Anstee","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2025.12.042_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/MCG.0000000000000215","article-title":"Prospective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis C","volume":"49","author":"Joo","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jfma.2025.12.042_bib8","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41598-017-03589-w","article-title":"New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2025.12.042_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","article-title":"Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort","volume":"57","author":"Holmberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2025.12.042_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","article-title":"The enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values","volume":"59","author":"Lichtinghagen","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2025.12.042_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/liv.12896","article-title":"The enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease","volume":"36","author":"Irvine","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2025.12.042_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.891398","article-title":"Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents","volume":"13","author":"Cossiga","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jfma.2025.12.042_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3343\/alm.2021.41.1.16","article-title":"Clinical utility of mac-2 binding protein glycosylation isomer in chronic liver diseases","volume":"41","author":"Tamaki","year":"2021","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jfma.2025.12.042_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12112650","article-title":"Serum mac-2 binding protein glycosylation isomer to predict the severity of hepatic fibrosis in patients with hepatitis C virus infection","volume":"12","author":"Liu","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.jfma.2025.12.042_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.11152\/mu-942","article-title":"Acoustic Radiation Force Impulse (ARFI) elastography for non-invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis","volume":"19","author":"Hu","year":"2017","journal-title":"Med Ultrasonogr"},{"key":"10.1016\/j.jfma.2025.12.042_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2013.03.013","article-title":"The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response","volume":"59","author":"D'Ambrosio","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2025.12.042_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.29557","article-title":"Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C","volume":"67","author":"Mauro","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib18","series-title":"Global health sector strategy on viral hepatitis 2016-2021: towards ending viral hepatitis","year":"2016"},{"key":"10.1016\/j.jfma.2025.12.042_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2025.12.042_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2025.12.042_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12072-019-09988-7","article-title":"APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation","volume":"13","author":"Kanda","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jfma.2025.12.042_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jum.15806","article-title":"Liver and spleen stiffness surveillance through elastography during and after direct-acting antiviral therapy in patients with chronic hepatitis C","volume":"41","author":"Chen","year":"2022","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jfma.2025.12.042_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?","volume":"107","author":"Lee","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.jfma.2025.12.042_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41379-018-0048-0","article-title":"Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification","volume":"31","author":"Theise","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jfma.2025.12.042_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.12.042_bib26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis regression after eradication of hepatitis C virus: from bench to bedside","volume":"160","author":"Rockey","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:59:28Z","timestamp":1773957568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625006990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S0929664625006990"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.12.042","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of fibrosis marker dynamics after hepatitis C cure: Insights from paired biopsies","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}